The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barrington, R. A.
Right arrow Articles by Carroll, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barrington, R. A.
Right arrow Articles by Carroll, M. C.
The Journal of Immunology, 2005, 175: 2859-2867.
Copyright © 2005 by The American Association of Immunologists

CD21/CD19 Coreceptor Signaling Promotes B Cell Survival during Primary Immune Responses1

Robert A. Barrington*, Ming Zhang2,*, Xuemei Zhong2,{ddagger}, Helena Jonsson*, Nichol Holodick{ddagger}, Anu Cherukuri{dagger}, Susan K. Pierce{dagger}, Thomas L. Rothstein{ddagger} and Michael C. Carroll3,*

* CBR Institute for Biomedical Research and Department of Pathology, Harvard University, Boston, MA 02115; {dagger} Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852; and {ddagger} Department of Immunobiology, Boston University Medical Center, Boston, MA 02118

The adaptive immune response is tightly regulated to limit responding cells in an Ag-specific manner. On B cells, coreceptors CD21/CD19 modulate the strength of BCR signals, potentially influencing cell fate. The importance of the CD95 pathway was examined in response of B cells to moderate affinity Ag using an adoptive transfer model of lysozyme-specific Ig transgenic (HEL immunoglobulin transgene (MD4) strain) B cells. Although adoptively transferred Cr2+/+ MD4 B cells are activated and persist within splenic follicles of duck egg lysozyme-immunized mice, Cr2–/– MD4 B cells do not. In contrast, Cr2–/– MD4 lpr B cells persist after transfer, suggesting that lack of CD21/CD35 signaling results in CD95-mediated elimination. Cr2 deficiency did not affect CD95 levels, but cellular FLIP (c-FLIP) protein and mRNA levels were reduced 2-fold compared with levels in Cr2+/+ MD4 B cells. In vitro culture with Cr2+/+ MD4 B cells demonstrated that equimolar amounts of rHEL-C3d3 were more effective than hen egg lysozyme alone in up-regulating c-FLIP levels and for protection against CD95-mediated apoptosis. Collectively, this study implies a mechanism for regulating B cell survival in vivo whereby the strength of BCR signaling (including coreceptor) determines c-FLIP levels and protection from CD95-induced death.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. C. Jacobson and J. H. Weis
Comparative Functional Evolution of Human and Mouse CR1 and CR2
J. Immunol., September 1, 2008; 181(5): 2953 - 2959.
[Full Text] [PDF]


Home page
J. Immunol.Home page
A. C. Jacobson, J. J. Weis, and J. H. Weis
Complement Receptors 1 and 2 Influence the Immune Environment in a B Cell Receptor-Independent Manner
J. Immunol., April 1, 2008; 180(7): 5057 - 5066.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. de Andres, I. Cortegano, N. Serrano, B. del Rio, P. Martin, P. Gonzalo, M. A. R. Marcos, and M. L. Gaspar
A Population of CD19highCD45R /lowCD21low B Lymphocytes Poised for Spontaneous Secretion of IgG and IgA Antibodies
J. Immunol., October 15, 2007; 179(8): 5326 - 5334.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Thomas, M. Calamito, B. Srivastava, I. Maillard, W. S. Pear, and D. Allman
Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation
Blood, April 15, 2007; 109(8): 3342 - 3350.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. C. van Zelm, I. Reisli, M. van der Burg, D. Castano, C. J.M. van Noesel, M. J.D. van Tol, C. Woellner, B. Grimbacher, P. J. Patino, J. J.M. van Dongen, et al.
An antibody-deficiency syndrome due to mutations in the CD19 gene.
N. Engl. J. Med., May 4, 2006; 354(18): 1901 - 1912.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.